Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01636479
Title Phase 1 Safety Testing of SAR405838
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sanofi
Indications

lymphoma

Advanced Solid Tumor

Therapies

SAR405838

Age Groups: adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Investigational Site Number 840101 Boston Massachusetts 02114 United States Details
Investigational Site Number 840001 Boston Massachusetts 02115 United States Details
Investigational Site Number 840002 New York New York 10021 United States Details
Investigational Site Number 250001 Villejuif 94805 France Details
Investigational Site Number 528001 Amsterdam 1066 CX Netherlands Details
Investigational Site Number 528003 Rotterdam 3075 EA Netherlands Details
Investigational Site Number 528002 Utrecht 3584 CX Netherlands Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field